Results 321 to 330 of about 1,399,966 (352)

Receptor-based bioassay for functional IL-2 quantification

Journal of Pharmaceutical and Biomedical Analysis
IL-2 is a potent cytokine that promotes multiple immune cells proliferation and activation. Accordingly, IL-2 based immunotherapies are emerging to treat cancers or AIDS by enhancing T cell growth and function. Besides, IL-2 is indispensable in in vitro cultivation of immune cells which is a critical step of CAR-T or CAR-NK immunotherapies.
Chuanwei Lu, Shuangshuang Xu, Xuelian Shan, Jiayu Wang, Xinyue Hu, Yuming Fang, Shanshan Wang, Grace Gong   +7 more
openaire   +2 more sources

Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

Immunology, 1989
A rat anti-interleukin-2 receptor (IL-2R) monoclonal antibody (mAb), AMT-13, has been shown to prolong cardiac allograft survival in mice. However, neither the mechanism of its immunosuppressive action, nor its other in vivo effects, have been studied extensively.
K, Burkhardt, T E, Mandel, T, Diamantstein, M S, Loughnan   +3 more
openaire   +1 more source

Structure and function of IL-2 and IL-2 receptors.

Behring Institute Mitteilungen, 1992
Cytokines, a class of soluble mediators involved in cell-to-cell communication, are generated in response to many stimuli by a variety of tissues. They include interferons (IFNs), Interleukins (ILs) and colony stimulation factors (CSFs), and have been most extensively studied in the context of hematopoiesis and immune responses, however their molecular
openaire   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

T cells expressing IL-2 receptor in migraine.

Acta neurologica, 1991
We studied a group of migraine patients for circulating immune complexes, lymphocyte subpopulations, IgG4 and anti-IgG antibodies, before, after 4 hours and after 72 hours a specific challenge test. We found an increased incidence of circulating immune complexes. Total T cells showed a marked increase after challenge test.
openaire   +2 more sources

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Abnormal Immunoregulation Involving the IL‐2/IL‐2 Receptor Complex in Myasthenia Gravis

Annals of the New York Academy of Sciences, 1993
S, Cohen-Kaminsky, J M, Duquenoy, S, Berrih-Aknin   +2 more
openaire   +2 more sources